Physician profile
Derek Ho
NPI 1174056691
$7,350.62
in general payments reported to CMS, 2019-2025
13 companies · $278 in 2025
The $278 reported for 2025 was more than what 86% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $167 · 2022: $447 · 2023: $6,010 · 2024: $449 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,536 · Food and Beverage: $1,450 · Travel and Lodging: $751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,536.00 |
| Food and Beverage | $1,450.11 |
| Travel and Lodging | $750.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $5,396.87 | 2023 | |
| Sun Pharmaceutical Industries INC. | $892.64 | 2021-2025 | Winlevi, Absorica Ld |
| Abbvie INC. | $247.93 | 2021-2024 | |
| Dermavant Sciences, INC. | $210.40 | 2022-2024 | Vtama |
| Leo Pharma INC. | $170.05 | 2025 | Adbry |
| Solta Medical, A Division of Bausch Health US, LLC | $115.71 | 2023 | |
| Kyowa Kirin, INC. | $73.28 | 2021 | |
| Almirall LLC | $65.48 | 2023 | Klisyri |
| Biofrontera INC. | $51.38 | 2022-2024 | Ameluz, Xepi, Bf-Rhodoled |
| Sanofi-Aventis U.S. LLC | $48.17 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $40.01 | 2025 | Cabtreo, Siliq, Jublia |
| Lilly USA, LLC | $23.58 | 2022 | |
| Journey Medical Corporation | $15.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.